chitosan has been researched along with Idiopathic Pulmonary Fibrosis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Singh, S; Wairkar, S | 1 |
| Hergert, P; Im, J; Jeon, S; Kim, H; Kim, K; Nho, RS; Panyam, J; Yhee, JY; Yoon, HY | 1 |
| Abnoos, M; Ashtari, K; Ilka, R; Mehravi, B; Mohseni, M; Mousavi, SAJ | 1 |
3 other study(ies) available for chitosan and Idiopathic Pulmonary Fibrosis
| Article | Year |
|---|---|
Long-circulating thiolated chitosan nanoparticles of nintedanib with N-acetyl cysteine for treating idiopathic pulmonary fibrosis: In vitro assessment of cytotoxicity, antioxidant, and antifibrotic potential.
Topics: Acetylcysteine; Antioxidants; Cell Line; Cell Survival; Chitosan; Humans; Idiopathic Pulmonary Fibrosis; Nanoparticles; Particle Size; Sulfhydryl Compounds | 2023 |
The effects of collagen-rich extracellular matrix on the intracellular delivery of glycol chitosan nanoparticles in human lung fibroblasts.
Topics: Amiloride; Cells, Cultured; Chitosan; Chlorpromazine; Collagen Type I; Drug Carriers; Drug Delivery Systems; Endocytosis; Extracellular Matrix; Fibroblasts; Genistein; Humans; Idiopathic Pulmonary Fibrosis; Lung; Nanoparticles; Phosphatidylinositol 3-Kinases | 2017 |
Chitosan-alginate nano-carrier for transdermal delivery of pirfenidone in idiopathic pulmonary fibrosis.
Topics: Administration, Cutaneous; Alginates; Animals; Chitosan; Drug Carriers; Glucuronic Acid; Hexuronic Acids; Humans; Idiopathic Pulmonary Fibrosis; Mice; Pyridones; Skin | 2018 |